AMNEAL PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.85B | $4.35B | $213.4M |
| FY2019 | $3.43B | $3.67B | $151.2M |
| FY2020 | $3.70B | $4.01B | $341.4M |
| FY2021 | $3.58B | $3.94B | $247.8M |
| FY2022 | $3.50B | $3.80B | $26.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.85B | $4.35B | $213.4M |
| FY2019 | $3.43B | $3.67B | $151.2M |
| FY2020 | $3.70B | $4.01B | $341.4M |
| FY2021 | $3.58B | $3.94B | $247.8M |
| FY2022 | $3.50B | $3.80B | $26.0M |